Research Projects & Grants

College/University

  • Phase 2 Study of Levetiracetam for Neonatal Seizures, Role: Co-PD/PI, University of California, San Diego, (09/2012 - 08/2015) Status: Closed

Federal

  • Radiation Medicine Central Nervous System Studies, Role: Co-Investigator, Department of Defense, (09/2010 - 10/2012) Status: Closed

For Profit Organization

  • Safety and Therapeutic Measures of Transcranial Cathodal Direct Current Stimulation (TDCS) in Patients with Refractory Focal Epilepsy. Protocol #: NE001, Role: Investigator, Neuroelectrics Corporation, (09/2024 - 09/2025) Status: Approved
  • A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi center Trial of CVL-865 as Adjunctive Therapy in Adults with Drug-Resistant Focal Onset Seizures (REALIZE TRIAL). Protocol Number: CVL-865-SZ-001, Role: PI, Cerevel Therapeutics, LLC, (06/2023 - 06/2024) Status: Completed
  • FIRST SEIZURE CLINIC & EMERGENCY DEPARTMENT INTERVENTION, Role: PD/PI, UCB Pharma, S. A., (09/2019 - 08/2022) Status: Awarded
  • ASCEND: Vagus nerve stimulation titration protocol to improve tolerance and accelerate adaptation, Role: PI, Cyberonics, Inc., (03/2016 - 03/2017) Status: Completed
  • Long-term eslicarbazepine acetate extension study. Protocol # 093-050, version 3.0, dated 24 Jul 2009. Informed consent form version dated 03Aug09. Investigator's brochure version 1.0, dated 26 Jan 2009, Role: PI, Sepracor, (09/2015 - 09/2016) Status: Completed
  • Double-blind, randomized, historical control study of the safety and efficacy of eslicarbazepine acetate monotherapy in subjects with partial epilepsy not well controlled by current antiepileptic drugs. Protocol #093-045; version 2.0, dated 04 Mar 2009. Informed consent form version date 5/22/2009. Investigator's brochure version 1.0, dated 26 Jan 2009., Role: PI, Sepracor, (05/2013 - 05/2014) Status: Completed
  • An open-label, multi-national, multi-center, follow-up study to evaluate the long-term safety and efficacy of brivaracetam, used at a flexible dose up to a maximum of 150 mg/day in subjects age16 years or older suffering from epilepsy. Protocol: RPCE08C0502, dated 18 April 2008. Study Number: N01315. Informed consent form version 1.0, dated 25 April 2008. Investigator's brochure version 8.0, dated 21 February 2008., Role: PI, UCB Biosciences Inc., (03/2010 - 03/2011) Status: Completed
  • An international, double-blind, randomized, multi-center, parallel group, historical-control conversion to monotherapy study to evaluate the efficacy and safety of brivaracetam in subjects (>_ 16 to 75 years old) with partial onset seizures with or without secondary generalization. Protocol:RPCE07F1216 integrated amendment 1, dated 04 April 2008. Study number:N01306. Informed consent version 1.0, dated 30 December 2008. Informed consent for collection of blood for genetic research version 1.0, dated 30 December 2008. Investigator's brochure version 8.0, dated 21 February 2008., Role: PI, UCB Pharma, S. A., (01/2010 - 01/2011) Status: Completed

Internal

  • First Time Seizure Clinic, Role: Investigator, LLU Dept. of Neurology, (06/2022) Status: Completed
  • Tracking Quality of Life and Seizure Burden in Epilepsy Surgical Candidates in Inland Southern California, Role: Investigator, LLU Dept. of Neurology, (03/2022) Status: Approved
  • Assessment of radiation exposure in epilepsy clinic patients, Role: PI, LLU Dept. of Neurology, (12/2019 - 12/2020) Status: Completed
  • Understanding the neural substrates of language, attention, motor control, emotion and memory processing, Role: Investigator, LLU Dept. of Neurology, (06/2019) Status: Approved
  • Review of the first year experience at SAC health system which may be the first federally funded qualified health care center (FQHS) based neurology clinics in the US: A retrospective study, Role: PI, LLU Dept. of Neurology, (01/2018 - 12/2023) Status: Completed
  • Diagnostic yield of inpatient EEGs, Role: PI, LLU Dept. of Neurology, (07/2011 - 07/2012) Status: Completed
  • Retrospective review of Magnetic Resonance Spectroscopy findings in patients with epilepsy, Role: PI, LLU Dept. of Neurology, (07/2010 - 07/2011) Status: Completed

Non-Profit Organization

  • Metabolic dysfunction in temporal lobe epilepsy revealed by ¹³C magnetic resonance spectroscopy, Role: PI, Epilepsy Foundation of America, (03/2017 - 03/2018) Status: Completed
  • Metabolic Dysfunction in Temporal Lobe Epilepsy Revealed by 13C MRS, Role: Principal Investigator, Epilepsy Foundation of America, (07/2012 - 02/2015) Status: Closed